Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Pathogens

    DTRA Award to Northern Arizona University for Melioidosis Research

    By Global Biodefense StaffFebruary 7, 2014
    Share
    Facebook LinkedIn Reddit Email

    Defense Threat Reduction Agency - Counter CBRNEThe U.S. Department of Defense has recently awarded a notable contract related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for applications in biodefense:

    Northern Arizona University, Flagstaff, Ariz, is being awarded a $6,988,284 cost-reimbursable contract for the characterization of antibody responses to melioidosis in humans and in animal models for the Defense Threat Reduction Agency in support of the Research and Development Enterprise.  Bids were solicited and nine received.  Work will be performed in Flagstaff, Ariz., and Darwin, Australia, and is expected to be completed February 2019.  The contracting activity is Defense Threat Reduction Agency, Fort Belvoir, Va, (HDTRA1-14-C-0022).  

    Source: Defense.gov

    Related excerpts from Northern Arizona University:

    –David Wagner, NAU Associate Professor in the Department of Biological Sciences and Associate Director of The Center for Microbial Genetics & Genomics, has brought aboard Katy Califf from Michigan State University to help analyze large genomic datasets to identify a possible new vaccine and therapeutic targets for melioidosis, a disease caused by the bacterium Burkholderia pseudomallei. “The ability to generate large amounts of genomic data has revolutionized the biomedical sciences. However, handling and analyzing these large datasets is not trivial and requires specialized skills—skills that currently do not exist in my research group,” Wagner explained. Califf brings that skillset to NAU. “This work has great potential to develop new intellectual property for NAU, and should also lead to more external funding,” said Wagner. (Spring 2013) Source: NAU Spring Newsletter

    — Kenzie Shippy and her team work with the Defense Threat Reduction Agency to differentiate pathogenic, disease-causing burkholderia from its non-pathogenic counterparts. She explains that current knowledge on burkholderia is scarce, and that discovering what makes it pathogenic is key in combating potential bioterrorism threats.

    “Because it is disease-causing and can be found in the soil, it gives it a really high potential of being used as a biological weapon,” Shippy says. “We want to sequence the DNA of non-pathogenic burkholderia and compare it to the pathogenic strains – how it differs will show us which genes are pathogenic and what can cause disease.”

    Troops stationed overseas could be easily exposed to soil containing burkholderia, for example, and Shippy says it is important to determine whether or not it’s naturally-occurring.  “One reason the Defense Agency is so focused on this bacteria is because it is so poorly understood,” Shippy says. “It could be easy for someone to acquire it, so we want to be able to develop tests that tell us whether it’s a pathogen or a non-pathogen.” Read the rest at NAU: Preventing Terrorism Through Bioscience (2013).

    Animal Models Awards Bioterrorism Burkholderia Defense Threat Reduction Agency Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleRFI – Advanced Development of Multiplex Diagnostics
    Next Article DHS Foreign Animal Disease Support Contract to McConnell Group

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.